221 related articles for article (PubMed ID: 25834073)
21. Role of the adaptive immune system in hypertension.
Harrison DG; Vinh A; Lob H; Madhur MS
Curr Opin Pharmacol; 2010 Apr; 10(2):203-7. PubMed ID: 20167535
[TBL] [Abstract][Full Text] [Related]
22. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury.
Shao J; Nangaku M; Miyata T; Inagi R; Yamada K; Kurokawa K; Fujita T
Hypertension; 2003 Jul; 42(1):31-8. PubMed ID: 12771047
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory cytokines regulate renal sodium transporters: how, where, and why?
Norlander AE; Madhur MS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F141-F144. PubMed ID: 28404590
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction.
Dong X; Bachman LA; Miller MN; Nath KA; Griffin MD
Kidney Int; 2008 Nov; 74(10):1294-309. PubMed ID: 18974760
[TBL] [Abstract][Full Text] [Related]
25. Hypertension and immunity: mechanisms of T cell activation and pathways of hypertension.
Abais-Battad JM; Rudemiller NP; Mattson DL
Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):470-4. PubMed ID: 26125645
[TBL] [Abstract][Full Text] [Related]
26. Immune-related effects in hypertension and target-organ damage.
Muller DN; Kvakan H; Luft FC
Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):113-7. PubMed ID: 21245763
[TBL] [Abstract][Full Text] [Related]
27. Immune modulation of resistance artery remodelling.
Schiffrin EL
Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):70-2. PubMed ID: 21740527
[TBL] [Abstract][Full Text] [Related]
28. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L
Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551
[TBL] [Abstract][Full Text] [Related]
29. Role of T-cell activation in salt-sensitive hypertension.
Ren J; Crowley SD
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1345-H1353. PubMed ID: 30901277
[TBL] [Abstract][Full Text] [Related]
30. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
Campese VM; Wurgaft A; Safa M; Bianchi S
J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
[TBL] [Abstract][Full Text] [Related]
31. Amplification of Salt-Sensitive Hypertension and Kidney Damage by Immune Mechanisms.
Mattson DL; Dasinger JH; Abais-Battad JM
Am J Hypertens; 2021 Feb; 34(1):3-14. PubMed ID: 32725162
[TBL] [Abstract][Full Text] [Related]
32. Role of immune cells in hypertension.
Caillon A; Paradis P; Schiffrin EL
Br J Pharmacol; 2019 Jun; 176(12):1818-1828. PubMed ID: 29952002
[TBL] [Abstract][Full Text] [Related]
33. Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.
Itani HA; McMaster WG; Saleh MA; Nazarewicz RR; Mikolajczyk TP; Kaszuba AM; Konior A; Prejbisz A; Januszewicz A; Norlander AE; Chen W; Bonami RH; Marshall AF; Poffenberger G; Weyand CM; Madhur MS; Moore DJ; Harrison DG; Guzik TJ
Hypertension; 2016 Jul; 68(1):123-32. PubMed ID: 27217403
[TBL] [Abstract][Full Text] [Related]
34. Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats.
Lan CZ; Ding L; Su YL; Guo K; Wang L; Kan HW; Ou YR; Gao S
Food Funct; 2015 Jul; 6(7):2179-86. PubMed ID: 26011796
[TBL] [Abstract][Full Text] [Related]
35. Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications.
Rai A; Narisawa M; Li P; Piao L; Li Y; Yang G; Cheng XW
J Hypertens; 2020 Oct; 38(10):1878-1889. PubMed ID: 32890260
[TBL] [Abstract][Full Text] [Related]
36. Immune mechanisms in hypertension.
Leibowitz A; Schiffrin EL
Curr Hypertens Rep; 2011 Dec; 13(6):465-72. PubMed ID: 21842150
[TBL] [Abstract][Full Text] [Related]
37. Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II.
Kirchhoff F; Krebs C; Abdulhag UN; Meyer-Schwesinger C; Maas R; Helmchen U; Hilgers KF; Wolf G; Stahl RA; Wenzel U
Kidney Int; 2008 Mar; 73(5):643-50. PubMed ID: 18033241
[TBL] [Abstract][Full Text] [Related]
38. Modulation of renal inflammation: therapeutic strategies.
Karkar A
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):1-19. PubMed ID: 18087117
[TBL] [Abstract][Full Text] [Related]
39. Innate immunity and clinical hypertension.
Van Beusecum JP; Moreno H; Harrison DG
J Hum Hypertens; 2022 Jun; 36(6):503-509. PubMed ID: 34689174
[TBL] [Abstract][Full Text] [Related]
40. Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice.
Honjo T; Chyu KY; Dimayuga PC; Lio WM; Yano J; Trinidad P; Zhao X; Zhou J; Cercek B; Shah PK
PLoS One; 2015; 10(6):e0131731. PubMed ID: 26121471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
